|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01276 HENGRUI PHARMA
Nominal 
75.600 -4.150 (-5.204%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | |
| Turnover | 15,761,194 | 15.885% | 13,600,734 |
| Cost of Sales | (2,114,962) | 12.900% | (1,873,304) |
| Gross Profit | 13,646,232 | 16.362% | 11,727,430 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (41,467) | 20.624% | (34,377) | |
| Profit / (Loss) before Taxation | 5,050,935 | 34.634% | 3,751,598 | |
| Taxation | (596,264) | 84.335% | (323,468) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | |
| Non-controlling Interests | (4,564) | -- | 3,616 | |
| Others | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 4,450,107 | 29.675% | 3,431,746 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (242,925) | -33.893% | (367,474) |
| Depreciation & Amortisation | 461,792 | 8.702% | 424,823 |
| Directors' Emoluments | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | |
| Auditor's Opinion Status | N/A | -- | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | |
| EPS (cts) | 70.000 | 29.630% | 54.000 |
| DPS (cts) | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- |
| NBV per share ($) | 8.820 | -- | -- |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,450,107 |
| %Change | 29.675% |
| EPS / (LPS) | RMB 0.700 |
| NBV Per Share (¥) | RMB 8.820 |